Page 3,043«..1020..3,0423,0433,0443,045..3,0503,060..»

DNA Genetics @ Cannafest 2014 Prague – Video

Posted: Published on December 8th, 2014

DNA Genetics @ Cannafest 2014 Prague Herbies Seeds Interview with Rowan from DNA Genetics @ Cannafest 2014 in Prague, Czech Republic. Buy DNA Genetics Seeds: http://www.herbiesheadshop.com/dna-genetics-seeds Watch Herbies ... By: Herbies Seeds … Continue reading

Posted in Genetics | Comments Off on DNA Genetics @ Cannafest 2014 Prague – Video

What Role Do Genetics Play For Muscle Gains/Fat Loss? Rodzilla & Hugo Candid Bodybuilding Talk – Video

Posted: Published on December 8th, 2014

What Role Do Genetics Play For Muscle Gains/Fat Loss? Rodzilla Hugo Candid Bodybuilding Talk http://www.HugoRivera.net - What Role Do Genetics Play For Muscle Gains? Rodney (aka Rodzilla) Hugo Candid Bodybuilding Talk. Hugo Rivera Rodney discuss the role that genetics play in ... By: HugoRiveraFitness … Continue reading

Posted in Genetics | Comments Off on What Role Do Genetics Play For Muscle Gains/Fat Loss? Rodzilla & Hugo Candid Bodybuilding Talk – Video

Seattle Genetics-Takeda’s Adcetris Shows Long-Term Effect – Analyst Blog

Posted: Published on December 8th, 2014

Seattle Genetics, Inc. ( SGEN ) and Takeda Pharmaceutical Company Limited ( TKPYY ) announced four-year overall survival data from a pivotal phase II study evaluating the efficacy and safety of Adcetris for the treatment of relapsed or refractory systemic anaplastic large cell lymphoma (ALCL). Adcetris showed durable, long-term responses in this treatment setting. At a median follow-up in the study at 46.3 months, the four-year survival rate was estimated to be 64% (median overall survival (OS) of 55.1 months) with progression-free survival (PFS) of 20 months. In other words, more than 60% of patients suffering from relapsed or refractory ALCL treated with Adcetris were alive at the fourth year of follow-up. One-third of all the patients treated in this study showed complete remission with no evidence of disease after a median follow-up of 46 months. The company stated that historical outcomes for patients suffering from relapsed T-cell lymphoma, including systemic ALCL have shown a median OS of 5.5 months with a median PFS of 3.1 months. Meanwhile, Seattle Genetics also announced detailed results from a randomized, double-blind, placebo-controlled phase III study (AETHERA) on Adcetris for the treatment of Hodgkin lymphoma patients with the risk of disease progression following autologous … Continue reading

Posted in Genetics | Comments Off on Seattle Genetics-Takeda’s Adcetris Shows Long-Term Effect – Analyst Blog

NYIT Expert Predicts Growth in Demand for 3D Kidneys, Livers and Hearts

Posted: Published on December 8th, 2014

Contact Information Available for logged-in reporters only Michael Hadjiargyrou, Ph.D., of New York Institute of Technologys College of Arts and Sciences, an expert in engineering new musculoskeletal tissue, is available to discuss advanced bio-science predictions for 2015. Undoubtedly, next year we will continue to see research advances in the realm of Tissue Engineering/Regenerative Medicine (TERM), says Hadjiargyrou, who specializes in molecular and cell biology, genetic engineering, biomaterials and stem cell research. Specifically, we will witness the formation of more tissues and possibly even organs fabricated in the laboratory with the use of 3D printers (Bioprinters). Hadjiargyrou specifically identifies the heart valve, blood vessel, trachea, kidney, and liver, as the tissue or organs that will be printed with the use of 3D printers; kidneys, livers and hearts are most in demand. Additionally, the successful transplantation of some of these laboratory tissues and organs will be achieved, particularly in Europe, as they have been more active in transplantation of biomaterials. With the emergence of such breakthroughs, we will begin to see more and more clinical and even cosmetic applications of TERM. Hadjiargyrou focuses on studying the molecular mechanisms involved in bone regeneration as a way to better understand the healing of fractures. … Continue reading

Posted in Genetic Engineering | Comments Off on NYIT Expert Predicts Growth in Demand for 3D Kidneys, Livers and Hearts

Gene Therapy Infomercial – Video

Posted: Published on December 8th, 2014

Gene Therapy Infomercial Song- Take The Plunge Heinz Ketchup ops I mean kiessling Voiced by Jesse W., Nestor F., Zachary E., and Zachary P. By: Nestor Falcon … Continue reading

Posted in Gene Therapy | Comments Off on Gene Therapy Infomercial – Video

Research in action at Marquette University | Spinal cord injuries – Video

Posted: Published on December 8th, 2014

Research in action at Marquette University | Spinal cord injuries Dr. Murray Blackmore is an assistant professor of biomedical sciences in the College of Health Sciences at Marquette University. Dr. Blackmore's research focuses on the use of gene therapy... By: MarquetteU … Continue reading

Posted in Gene Therapy | Comments Off on Research in action at Marquette University | Spinal cord injuries – Video

Bluebird Gene Therapy Inducing Durable Cures in Blood Disorder Patients

Posted: Published on December 8th, 2014

SAN FRANCISCO (TheStreet) -- Bluebird Bio (BLUE) has now treated seven beta-thalassemia patients with its experimental, one-time gene therapy. Four of the patients -- all followed for longer than three months -- are producing enough oxygen-carrying hemoglobin on their own to eliminate the need for chronic blood transfusions. Two of these super-responding beta-thalassemia patients -- followed for a year and nine months, respectively -- have hemoglobin levels of healthy adults. At this point, a single infusion of Bluebird's gene therapy has essentially cured them of this serious, inherited blood disease. The remaining three beta-thalassemia patients were infused with Bluebird's gene therapy around one month ago so it's too early to assess their response. A single patient with sickle cell disease was also just treated within the past month. It's still unreasonable to expect an equivalent strong response in every patient, but Bluebird is learning that as its therapy replaces the defective gene causing beta-thalassemia (or sickle cell disease) with a gene that is fully functional, the patient's ability to produce normal-functioning hemoglobin improves over time, said CEO Nick Leschly. More: Bluebird Gene Therapy Inducing Durable Cures in Blood Disorder Patients … Continue reading

Posted in Gene Therapy | Comments Off on Bluebird Gene Therapy Inducing Durable Cures in Blood Disorder Patients

Pfizer Bets On Gene Therapy

Posted: Published on December 8th, 2014

LONDON Pfizer Inc. is moving into the gene therapy space in the latest sign that the technology for fixing faulty genes may finally be ready for prime time, following earlier setbacks. The U.S. drugmaker said on Monday it was establishing a gene therapy platform to study potential treatments, led by a top UK expert, and had struck a deal with privately owned U.S. biotech firm Spark Therapeutics to develop a treatment for hemophilia. The Spark program is expected to enter early-stage clinical trials for hemophilia B in the first half of 2015. Spark will be responsible for the early Phase I/II tests, with Pfizer taking over late-stage studies, any regulatory approvals and potential commercialization. Spark will get $20 million upfront and be eligible for additional payments based on product success worth up to $260 million. Pfizer's research effort in gene therapy will be led by Michael Linden, a professor from King's College London and director of the University College London Gene Therapy Consortium. Linden is joining Pfizer on a two-year secondment. Gene therapy has seen more than 20 years of experiments but research has been dogged by a series of disappointments and safety concerns. Now, however, scientists have solved some … Continue reading

Posted in Gene Therapy | Comments Off on Pfizer Bets On Gene Therapy

Embryology _ Roger Raafat – Video

Posted: Published on December 8th, 2014

Embryology _ Roger Raafat By: Asm Acad … Continue reading

Posted in Embryology | Comments Off on Embryology _ Roger Raafat – Video

AMU library opens its doors to Women’s College students

Posted: Published on December 8th, 2014

ALIGARH: It was in the 1960s that the undergraduate girls of Abdullah Women's College were told they would no more have access to AMU's hallowed Maulana Azad Library. After decades of demand, denial and heartburn, in what many said was one of the university's most landmark events, girl students stepped into the library once again The first bus left the Women's College campus with eight girls at 8.30 am, but more joined later. Inside the library, many just looked around in awe at the structure and soaked in the feeling, still coming to terms with the new reality. Others exchanged high-fives and withdrew the books they had always wanted to. "It's a historic day for the women students of AMU and for the university itself," one of them said. The controversy that erupted on November 10, when the AMU VC Zameeruddin Shah said allowing girls to access the central library of the 94-year-old institution was not possible owing to space constraint and that such a move would lead to "four times more boys" crowding the "packed" facility, was put to rest on a nippy December morning. "Any idea which is new takes time to fructify, this time only eight girls … Continue reading

Posted in Embryology | Comments Off on AMU library opens its doors to Women’s College students

Page 3,043«..1020..3,0423,0433,0443,045..3,0503,060..»